L-701,677

Class: Macrolide (15-membered macrolide)

Spectrum of activity:	Gram-positive  &  Gram-negative
Details of activity:	At least 4 fold more active against a Klebsiella infection than clarithromycin and erythromycin
Description:	Gill CJ, Abruzzo GK, Flattery A, et al. In vivo evaluation of three acid-stable azalide compounds, L-701677, L-708299 and L-708365 in comparison with erythromycin, azithromycin, and clarithromycin. 33rd-Intersci-Conf-Antimicrobial-Agents-Chemother 1993; 197.
Institute where first reported:	Merck & Co., USA
Year first mentioned:	1993
Highest developmental phase:	Preclinical
Development status:	Inactive

Chemical structure(s):
Canonical SMILES:	CC[C@@H]1[C@](C)([C@@H]([C@@H](C)CN(C)[C@H](C)C[C@](C)([C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O1)O[C@H]2C[C@](C)([C@H]([C@H](C)O2)O)OC)O[C@H]3[C@@H]([C@H](C[C@@H](C)O3)N(C)C)O)O)O)O
Isomeric SMILES:	CC[C@@H]1[C@@]([C@@H]([C@H](CN([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
InChI:	InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)20(2)19-40(13)21(3)17-36(8,45)33(52-35-29(41)26(39(11)12)16-22(4)48-35)23(5)30(24(6)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21+,22+,23-,24+,25-,26-,27+,28-,29+,30-,31+,32-,33+,35-,36+,37+,38+/m0/s1
InChI Key:	CVVWWIGGJJALDG-CFLXSVEWSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/9810699

External links:
Guide to Pharmacology:	L-701677